Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol.

Autor: Grimbergen G; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., Eijkelenkamp H; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., Snoeren LMW; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., Bahij R; Department of Oncology, Odense University Hospital, Denmark., Bernchou U; Department of Oncology, Odense University Hospital, Denmark.; Department of Clinical Research, University of Southern Denmark, Denmark., van der Bijl E; Department of Radiation Oncology, Radboudumc, Nijmegen, The Netherlands., Heerkens HD; Department of Radiation Oncology, Radboudumc, Nijmegen, The Netherlands., Binda S; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Ng SSW; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada., Bouchart C; Department of Radiation Oncology, HUB Institut Jules Bordet, Brussels, Belgium., Paquier Z; Department of Radiation Oncology, HUB Institut Jules Bordet, Brussels, Belgium., Brown K; Radiation Oncology, ONJ Centre, Austin Health, Heidelberg, Victoria, Australia., Khor R; Radiation Oncology, ONJ Centre, Austin Health, Heidelberg, Victoria, Australia., Chuter R; The Christie NHS Foundation Trust, Manchester, UK., Freear L; The Christie NHS Foundation Trust, Manchester, UK., Dunlop A; The Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK., Mitchell RA; The Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK., Erickson BA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Godoy Scripes P; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tyagi N; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Leon J; GenesisCare, Darlinghurst, New South Wales, Australia., Tran C; GenesisCare, Darlinghurst, New South Wales, Australia., Oh S; Division of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, USA., Renz P; Division of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, USA., Shessel A; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Taylor E; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Intven MPW; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2024 May 18; Vol. 47, pp. 100797. Date of Electronic Publication: 2024 May 18 (Print Publication: 2024).

OC-0782 Impact of advancing radiographer practice on MRL treatment times

Autor: Clough, A., Benson, R., Nelder, C., McDaid, L., Freear, L., Chuter, R., Berresford, J., Eccles, C.

Publikováno v: In Radiotherapy and Oncology May 2023 182 Supplement 1:S653-S653

The impact of gadolinium-based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac.

Autor: Hales RB; Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK., Chuter R; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., McWilliam A; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., Salah A; Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK., Dubec M; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., Freear L; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., McDaid L; Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK., Aznar M; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., van Herk M; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK., McPartlin A; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Eccles CL; Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

Publikováno v: Medical physics [Med Phys] 2022 Jan; Vol. 49 (1), pp. 510-520. Date of Electronic Publication: 2021 Nov 22.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PO-1572 Lessons learnt from the first radical cervix treatment on the MR-Linac.

Autor: Freear, L. (AUTHOR), Berresford, J. (AUTHOR), Chuter, R. (AUTHOR), Budgell, G. (AUTHOR), Whitehurst, P. (AUTHOR)

Publikováno v: Radiotherapy & Oncology. 2021 Supplement 1, Vol. 161, pS1297-S1298. 2p.